Atlas Trials

What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

Clinical trial NCT07210034 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07210034
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Myelo Dysplastic Syndrome
Start date
2026-01-01
Primary completion
2028-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.